Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Peringkat dalam Saham #33689
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Harga Saham
$4.70
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$7.09M
Perubahan (1 hari)
-0.21%
Perubahan (1 tahun)
-70.63%
Negara
US
Perdagangan Apimeds Pharmaceuticals US, Inc (APUS)

Kategori

Riwayat hasil dividen untuk Apimeds Pharmaceuticals US, Inc (APUS)
Hasil dividen (TTM) dari Apimeds Pharmaceuticals US, Inc (simbol saham: APUS) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Apimeds Pharmaceuticals US, Inc (APUS) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing